Cloning and Germline Intervention: U.S. Perspectives
By Marcy Darnovsky
| 10. 13. 2003
Perspectives on Reproductive Technologies and Biomedicine
Presentation at The Within and Beyond Human Nature conference, Berlin, Germany
Unlike selective abortion and PGD, the reproductive genetic
procedures on which I'm going to focus today are not being used
in doctors' offices and fertility clinics. No human child has
been produced by means of germline engineering or reproductive
cloning. But the discussion of these possibilities is well underway
in the United States, and that discussion is itself already
shaping our political values and social futures.
I'm going to try in the next few minutes to give you a quick
overview of how germline engineering (or inheritable genetic
modification) and reproductive cloning are being discussed in
the U.S.
First a very brief description of the mainstream advocacy
in the U.S. of these techniques of inheritable genetic modification-that
is, for the production of "enhanced children," or
what the U.S. media often call "designer babies."
Second, some comments on the challenges of convincing U.S.
progressives and feminists that the adoption of these practices
would pose grave threats to their own commitments to social
justice and equality-and that opposing these procedures...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...